Korean Botox Brands: Letybo and Nabota Guide 2026

The botulinum toxin market is no longer limited to a single dominant brand. Alongside Allergan Botox and Merz Xeomin, Korean products such as Letybo and Nabota are now part of real-world treatment planning in many clinics.

For patients, the important question is not whether a product is Korean or American, but whether it is original, properly stored, legally sourced, and matched to the right treatment plan. Brand choice matters, but injector judgement matters more.

1. What Letybo and Nabota Bring to the Market

Letybo by Hugel and Nabota by Daewoong are botulinum toxin type A products developed in South Korea. They are widely discussed because they promise a balance of clinical performance and lower cost compared with older premium brands.

In practice, both products are evaluated through the same lens as any other toxin: onset speed, diffusion profile, consistency of response, immunogenicity concerns, and reliability of the distribution chain.

• Letybo is often described as a faster-onset option in some treatment settings
• Nabota is positioned as a well-known Korean alternative with broad international use
• neither product should be chosen on price alone

2. How They Compare with Allergan Botox and Xeomin

Allergan Botox remains the reference brand for many injectors because of its long track record and highly familiar dose behavior. Xeomin is often highlighted for its purified formula without complexing proteins, which can be relevant in long-term planning for selected patients.

Korean toxins can be very reasonable options when the product is authentic and the clinician understands its practical behavior. The brand should be selected according to treatment goals, expected onset, patient history, and confidence in the supply chain.

• Allergan Botox is often the most familiar benchmark
• Xeomin is valued for a purified protein profile
• Korean brands can be effective, but authenticity and handling are critical

3. What Patients Should Ask Before Choosing a Brand

Patients often focus on the name of the vial, but the safer questions are more practical: Is the product original? Is it supplied through an authorized route? How is it stored? Which brand does the injector personally use most confidently?

A lower price is not automatically a better decision if the product origin is unclear or the injector is unfamiliar with its clinical behavior. In toxin treatments, trust in the clinician and clinic standards is more valuable than chasing the cheapest vial.

• ask about originality and authorized sourcing
• ask how the clinic stores and reconstitutes toxins
• ask which brand your doctor finds most predictable for your anatomy

4. Which Patients May Prefer Which Option?

Patients who want the most established benchmark often feel more comfortable with Allergan Botox. Patients with specific long-term planning concerns may discuss Xeomin. Those seeking a more cost-conscious option may consider Korean brands, provided the clinic uses authentic products and has experience with them.

The best choice is individualized. The goal is not to defend one brand ideologically, but to select the product that offers the most reliable and natural outcome for the planned treatment area.

• the best brand is the one that is authentic, appropriate, and well used by your injector
• cost should be balanced against predictability and clinic standards
• results depend on anatomy and technique more than on marketing reputation